Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2020-05-28 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
北京市康达律师事务所关于公司2019年限制性股票激励计划第一个解除限售期解除限售条件成就的法律意见
Regulatory Filings Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the achievement of the first unlocking period conditions of a 2019 restricted stock incentive plan for Tianjin Ruipu Biotechnology Co., Ltd. It contains detailed legal analysis, references to company board and shareholder approvals, and compliance with relevant laws and regulations. The document is not a financial report, earnings release, or management discussion, but a legal opinion related to a stock incentive plan. It is not an announcement of a report publication but a substantive legal opinion document. This fits best under the category of Regulatory Filings (RNS), as it is a regulatory compliance-related legal opinion and does not fit other more specific categories like Remuneration Information or Capital/Financing Update. The document length and content confirm it is not a brief announcement or a proxy solicitation but a detailed legal opinion.
2020-05-28 Chinese
关于2019年限制性股票激励计划第一个解除限售期解除限售条件成就的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding the achievement of the first unlocking period conditions for the 2019 restricted stock incentive plan. It details the number of incentive recipients, shares to be unlocked, approval procedures, performance assessments, and legal opinions. The content focuses on the status and conditions of stock incentive plan unlocking, including board and supervisory committee approvals, independent director opinions, and legal opinions. It is not a full financial report, earnings release, or management discussion, but rather a formal announcement about the stock incentive plan's unlocking event and related corporate governance matters. This fits best under the category of Regulatory Filings (RNS), as it is a regulatory announcement about stock incentive plan conditions being met and shares being unlocked, without substantive financial statements or detailed financial analysis. The document length (7118 characters) and detailed content confirm it is not a brief report publication announcement or a simple notice but a formal regulatory disclosure.
2020-05-28 Chinese
独立董事对第四届董事会第二十次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters discussed at a board meeting, including approval of a restricted stock incentive plan and the establishment of a controlled subsidiary. It references compliance with company law, stock exchange listing rules, and company articles of association. The content focuses on board-level decisions and opinions rather than financial results or audit findings. The document length is short (1605 characters) and does not contain financial statements or detailed financial data. It is not a report itself but a formal board/management information disclosure regarding corporate governance and board decisions.
2020-05-28 Chinese
上海荣正投资咨询股份有限公司关于公司2019年限制性股票激励计划第一期解除限售条件成就之独立财务顾问意见
Capital/Financing Update Classification · 95% confidence The document is an independent financial advisor's opinion report regarding the achievement of the first phase of lifting restrictions on restricted stock under the 2019 restricted stock incentive plan of Tianjin Ruipu Biotechnology Co., Ltd. It includes detailed explanations of the stock incentive plan, approval procedures, performance assessment, and the number of shares eligible for lifting restrictions. The document is not a full annual or interim financial report, nor is it a simple announcement or certification. It is a specialized advisory report related to a stock incentive plan and its compliance with relevant laws and regulations. This type of document fits best under the category of Capital/Financing Update (CAP), as it deals with stock incentive plans and related equity capital matters.
2020-05-28 Chinese
关于对外投资设立控股子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Tianjin Ruipu Biological Technology Co., Ltd. regarding an external investment to establish a controlling subsidiary company. It details the background, investment amount, shareholder structure, board composition, and strategic rationale for the investment. The document includes information about the investment approval by the board, the nature of the investment, and the expected impact and risks. There are no financial statements or detailed financial performance data included. The document is a formal announcement of a capital investment transaction and the establishment of a subsidiary, not a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2020-05-28 Chinese
第四届监事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Tianjin Ruipu Biotechnology Co., Ltd. It details decisions made during the 15th meeting of the 4th Supervisory Board, including approval of a restricted stock incentive plan release and the establishment of a holding subsidiary. The document includes voting results and references to further shareholder meetings and disclosures on the official regulatory website. It is not a full financial report, audit, or earnings release, but rather a formal announcement of board resolutions and related corporate governance matters. Therefore, it fits best under Board/Management Information (MANG). The document length is short (1529 characters), and it contains substantive content about board decisions, not just an announcement of a report publication or a certification letter.
2020-05-28 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.